HomeHOWL • NASDAQ
add
Werewolf Therapeutics Inc
Previous close
$2.20
Day range
$2.24 - $2.77
Year range
$1.57 - $8.19
Market cap
119.07M USD
Avg Volume
448.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 742.00K | -83.38% |
Operating expense | 5.00M | 0.30% |
Net income | -16.19M | -35.14% |
Net profit margin | -2.18K | -713.06% |
Earnings per share | -0.39 | -14.71% |
EBITDA | -16.70M | -41.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 139.19M | -5.87% |
Total assets | 177.60M | -8.96% |
Total liabilities | 60.01M | -18.90% |
Total equity | 117.59M | — |
Shares outstanding | 43.46M | — |
Price to book | 0.81 | — |
Return on assets | -24.35% | — |
Return on capital | -25.83% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -16.19M | -35.14% |
Cash from operations | -15.30M | -54.55% |
Cash from investing | -111.00K | 33.93% |
Cash from financing | 20.26M | -58.33% |
Net change in cash | 4.85M | -87.42% |
Free cash flow | -10.56M | -93.32% |
About
Founded
2017
Headquarters
Website
Employees
46